Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.

Elverdi T. , Eskazan A.

Drug design, development and therapy, vol.13, pp.1251-1258, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 13
  • Publication Date: 2019
  • Doi Number: 10.2147/dddt.s134470
  • Title of Journal : Drug design, development and therapy
  • Page Numbers: pp.1251-1258